These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31392836)

  • 1. Metal-based phosphorus dendrimers as novel nanotherapeutic strategies to tackle cancers: A concise overview.
    Chen L; Mignani S; Caminade AM; Majoral JP
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1577. PubMed ID: 31392836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Original Multivalent Gold(III) and Dual Gold(III)-Copper(II) Conjugated Phosphorus Dendrimers as Potent Antitumoral and Antimicrobial Agents.
    Mignani SM; El Brahmi N; El Kazzouli S; Laurent R; Ladeira S; Caminade AM; Pedziwiatr-Werbicka E; Szewczyk EM; Bryszewska M; Bousmina MM; Cresteil T; Majoral JP
    Mol Pharm; 2017 Nov; 14(11):4087-4097. PubMed ID: 28960997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Original multivalent copper(II)-conjugated phosphorus dendrimers and corresponding mononuclear copper(II) complexes with antitumoral activities.
    El Brahmi N; El Kazzouli S; Mignani SM; Essassi el M; Aubert G; Laurent R; Caminade AM; Bousmina MM; Cresteil T; Majoral JP
    Mol Pharm; 2013 Apr; 10(4):1459-64. PubMed ID: 23410260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer copper(II) phosphorus dendrimers are potent proapoptotic Bax activators.
    Mignani S; El Brahmi N; Eloy L; Poupon J; Nicolas V; Steinmetz A; El Kazzouli S; Bousmina MM; Blanchard-Desce M; Caminade AM; Majoral JP; Cresteil T
    Eur J Med Chem; 2017 May; 132():142-156. PubMed ID: 28350998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivalent Copper(II)-Conjugated Phosphorus Dendrimers with Noteworthy
    Mignani S; Shi X; Steinmetz A; Majoral JP
    Mol Pharm; 2021 Jan; 18(1):65-73. PubMed ID: 33236637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent Anticancer Efficacy of First-In-Class Cu
    Chen L; Fan Y; Qiu J; Laurent R; Li J; Bignon J; Mignani S; Caminade AM; Shi X; Majoral JP
    Chemistry; 2020 May; 26(26):5903-5910. PubMed ID: 32142179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorus dendrimers for nanomedicine.
    Caminade AM
    Chem Commun (Camb); 2017 Aug; 53(71):9830-9838. PubMed ID: 28745767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-Class Phosphorus Dendritic Framework, a Wide Surface Functional Group Palette Bringing Noteworthy Anti-Cancer and Anti-Tuberculosis Activities: What Lessons to Learn?
    Mignani S; Bignon J; Shi X; Majoral JP
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34204564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorus Dendrimers as Nanotools against Cancers.
    Caminade AM
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32708025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in multifunctional dendrimer-based complexes for cancer treatment.
    Shcharbin D; Zhogla V; Abashkin V; Gao Y; Majoral JP; Mignani S; Shen M; Bryszewska M; Shi X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1951. PubMed ID: 38456205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-in-Class Combination Therapy of a Copper(II) Metallo-Phosphorus Dendrimer with Cytotoxic Agents.
    Mignani S; El Brahmi N; Cresteil T; Majoral JP
    Oncology; 2018; 94(5):324-328. PubMed ID: 29533961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendrimers for cancer immunotherapy: Avidity-based drug delivery vehicles for effective anti-tumor immune response.
    Rawding PA; Bu J; Wang J; Kim DW; Drelich AJ; Kim Y; Hong S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Mar; 14(2):e1752. PubMed ID: 34414690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From metallodrugs to metallodendrimers for nanotherapy in oncology: a concise overview.
    El Kazzouli S; El Brahmi N; Mignani S; Bousmina M; Zablocka M; Majoral JP
    Curr Med Chem; 2012; 19(29):4995-5010. PubMed ID: 22963626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives.
    Cheng Y; Zhao L; Li Y; Xu T
    Chem Soc Rev; 2011 May; 40(5):2673-703. PubMed ID: 21286593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-antigens charged on phosphorus dendrimers as tools for tolerogenic dendritic cells-based immunotherapy.
    Vacas-Córdoba E; Bastida H; Pion M; Hameau A; Ionov M; Bryszewska M; Caminade AM; Majoral JP; Muñoz-Fernández MÁ
    Curr Med Chem; 2014; 21(16):1898-909. PubMed ID: 24304285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curing inflammatory diseases using phosphorous dendrimers.
    Caminade AM; Turrin CO; Poupot R
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1783. PubMed ID: 35194953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in dendrimer-based nanomedicine development.
    Kim Y; Park EJ; Na DH
    Arch Pharm Res; 2018 Jun; 41(6):571-582. PubMed ID: 29450862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of nanoscale dendritic RGD clusters for potential applications in tissue engineering and drug delivery.
    Yang H; Kao WJ
    Int J Nanomedicine; 2007; 2(1):89-99. PubMed ID: 17722516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle-Mediated Multiple Modulation of Bone Microenvironment To Tackle Osteoarthritis.
    Zhan M; Sun H; Wang Z; Li G; Yang R; Mignani S; Majoral JP; Shen M; Shi X
    ACS Nano; 2024 Apr; 18(15):10625-10641. PubMed ID: 38563322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional Dendrimer-Entrapped Gold Nanoparticles Conjugated with Doxorubicin for pH-Responsive Drug Delivery and Targeted Computed Tomography Imaging.
    Zhu J; Wang G; Alves CS; Tomás H; Xiong Z; Shen M; Rodrigues J; Shi X
    Langmuir; 2018 Oct; 34(41):12428-12435. PubMed ID: 30251859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.